European Journal of Rheumatology
Short Communication

A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics

1.

Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA

2.

Division of Rheumatology, UCLA School of Medicine, Los Angeles, CA, USA

Eur J Rheumatol 2020; 7: Supplement S102-S106
DOI: 10.5152/eurjrheum.2020.2065
Read: 301 Downloads: 138 Published: 22 May 2020

Cite this article as: Lakhanpal A, Brahn E. A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics. Eur J Rheumatol 2020; 7(Suppl 2): S102-6.

Files
ISSN2147-9720 EISSN 2148-4279